. . . "Others, such as Germany ??? at least with the first instance ruling of the German Federal Patent Court - have so far opted for a much more restrictive interpretation of the Directive.The opinion of the Advocate General Yves BotEuropean Court of Justice: Image by SsolbergjIn his opinion the Advocate General made a suggestion on how Art. 6 (2) (c) of the Biopatent Directive and its terms should be u" .